trp2 peptide TRP2 Peptide - prestige-peptides stimulates cytotoxic T-cell responses Unlocking the Potential of the TRP2 Peptide in Cancer Immunotherapy

price-of-collagen-peptides-vital-proteins The TRP2 peptide is emerging as a significant player in the field of cancer immunotherapy, particularly in the fight against melanoma.VRP-TRP2 has a potent anti-tumor effectin a prophylactic setting. Kaplan-Meier tumor-free survival curves are shown for 10/15 mice per group. As a component of Tyrosinase-related Protein 2 (TRP-2), also known as DCT or L-dopachrome tautomerase, this peptide holds promise due to its role as a melanocyte differentiation antigen. Research indicates that TRP2 peptide can be a target for immunotherapy, stimulating immune responses against melanoma and other neoplasms, including glioma.

Understanding the TRP2 Peptide

Tyrosinase-related protein-2 (TRP-2) is a protein found in melanocytes, the cells responsible for producing melanin. Its primary function is catalyzing the conversion of L-dopachrome into 5,6-dihydroxyindole-2-carboxylic acid (DHICA), a crucial step in melanin synthesisThe “cryptic” mechanism of action of glucagon-like peptide-2. However, its significance extends beyond pigmentation. TRP-tyrosinase-related protein and its derived peptides, such as the TRP2 peptide (180-188) with the sequence SVYDFFVWL, are recognized as key epitopes by the immune system. Specifically, the TRP-2 peptide (181-188) has been identified as a primary epitope recognized by anti-TRP2 antibodies and can conform to the MHC class I H2-Kb binding motif.

TRP2 Peptide in Cancer Treatment Strategies

The therapeutic potential of the TRP2 peptide lies in its ability to elicit an immune response against cancer cells that express this antigen. This has led to the development of various strategies utilizing TRP2 peptides for cancer treatment:

* Peptide Vaccines: TRP2 peptide can be used as a component of cancer vaccines. Studies have explored Trp2 peptide vaccine formulations, often adjuvanted with compounds like (R)-DOTAP, to enhance their immunogenicityA second tyrosinase-related protein, TRP-2, is a melanogenic enzyme .... These vaccines aim to prime the immune system, particularly cytotoxic T lymphocytes (CTLs), to recognize and attack cancer cells expressing TRP-2. Research has shown that Trp2 peptides plus CpG-oligodeoxynucleotide treatment can induce Ag-specific IFN-γ and CD8+ CTL responses, leading to antitumor activity.Multifunctional nanoparticles co-delivering Trp2 peptideand CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis ... Furthermore, Trp2 peptide-loaded nanoparticles (TRP2 peptide-loaded NPs) co-delivered with adjuvants like poly-IC have demonstrated the ability to efficiently induce TRP2-specific CTLs in melanoma models.

* Nanoparticle Delivery Systems: Overcoming the challenges associated with formulating hydrophobic peptides like Trp2 peptide, researchers have developed advanced delivery systems.TRP2 Antibody (D-18) has been replaced by a more specific monoclonal antibody, TRP2 (C-9) that provides a stronger signal & more reproducible data. Trp2 peptide-assembled nanoparticles and multifunctional nanoparticles co-delivering Trp2 peptide are being investigated.TRP2 (K89) Peptide These nanoparticles can effectively deliver the TRP2 peptide to antigen-presenting cells, such as dendritic cells (DCs), thereby enhancing the immune responseThispeptidecan be used with studies using BS3320TRP2(K89) pAb. Browse similar products>>. Size, Price. 1mg, 8. Datasheet · COA · MSDS · SHIP. Datasheet .... For example, using MgAl-layered double hydroxide nanoparticles co-delivering Trp2 peptide and siIDO has shown significant inhibition of tumor growth compared to free Trp2 peptideThe “cryptic” mechanism of action of glucagon-like peptide-2.

* Immunotherapy Enhancement: The TRP2 peptide can also be used to augment existing immunotherapies. Strategies involving the use of R-DOTAP as an adjuvant for Trp2 peptide have shown efficacy in aggressive murine solid tumor melanoma models.Multifunctional nanoparticles co-delivering Trp2 peptideand CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis ... Additionally, cell penetrating peptides like CPP1 can efficiently deliver the TRP2 peptide into mature DCs, retaining their capacity to present MHC-peptide complexes to antigen-specific T cells, a crucial step in initiating an anti-tumor immune response.

Challenges and Future Directions

While the TRP2 peptide shows significant promise, challenges remain. The inherent hydrophobicity of the Trp2 peptide can make formulation into aqueous solutions or delivery vehicles difficult. However, innovative approaches like nanoparticle assembly and the use of specific adjuvants are addressing these limitations.Synthetic TRP2 long-peptide and α-galactosylceramide ...

Research into TRP2 proteins and TRP2 Peptides for applications in ELISA, protein arrays, and Western blots continues, aiding in fundamental understanding and diagnostic development. While TRP2 Antibody (D-18) has been superseded by more specific antibodies, the broader investigation into TRP-2 related targets underscores the importance of this protein family in cancer research.Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits ...

The ongoing exploration of Tyrosinase-Related Protein2 Peptide with modifications, such as N-terminus residue replacement by cysteine, is yielding peptides that bind to H-2Kb and induce antigen-specific cytotoxic responses. This suggests a continuous evolution in the design and application of TRP2 peptide-based therapies.

In conclusion, the TRP2 peptide represents a compelling avenue for developing novel cancer immunotherapies.作者：EA Vasievich·2011·被引用次数：80—Viral delivery of Trp2 peptide or protein has shownnon-robust immunitycompared to the statistically significant tumor growth delay we see with (R)-DOTAP/Trp2 ... Its role as a melanocyte differentiation antigen, coupled with advancements in peptide delivery and combination therapies, positions it as a key target for future research and potential clinical applications against challenging cancers like melanoma. The pursuit of effective peptide-based treatments, including those utilizing TRP2 peptide-loaded NPs, continues to hold significant therapeutic potentialThis peptide is derived from tyrosinase-related protein 2 (TRP-2) residues 180-188.TRP-2 peptide, also named L-dopachrome tautomerase, H-2KB or DCT, ....